Urol. praxi, 2014; 15(3): 104-107 [Med. praxi. 2014;11(4):171-174]

Guidelines for diagnosis and treatment of erectile dysfunction

MUDr.Ta»ána ©rámková, CSc.
Urologická klinika a Sexuologický ústav 1. LF UK a VFN Praha
LF Masarykovy univerzity Brno
Sexuologické oddělení FN Brno

Erectile dysfunction is defined as an inability to achieve and maintain an erection sufficient for satisfactory sexual intercourse. ED is commnon

worldwide. ED shares risk factors with cardiovascular disease. Erectile dysfunction is a predictor of a serious cardiovascular event in men. Lifestyle

modification (intensive exercise and decrease in BMI) can improve erectile function. Modern oral form of ED therapy by PDE5 inhibitors

is safe and effective and is well tolerated. A new method in erectile dysfunction therapy is low intensity extracorporeal shock wave therapy

which produces neovascularisation. Intracavernosal therapy is safe and effective in diabetics and men after radical prostatectomy.

Keywords: erectile dysfunction, cardiovascular risk, PDE 5 inhibitors, intracavernosal therapy, shock wave therapy

Published: July 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
©rámková T. Guidelines for diagnosis and treatment of erectile dysfunction. Urol. praxi. 2014;15(3):104-107.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54-61. Go to original source... Go to PubMed...
    2. Hatzimouratidis K, Eardley I, Giuliano F, et al. Guidelines on male sexual dysfunction: Erectile dysfunction and premature ejaculation 2014 http://www.uroweb.org/. Go to original source...
    3. Pohanka M, Stárka L. Erektilní dysfunkce a jejich léčba. 1. vydání, Praha, Maxdorf 2011: 140.
    4. Breza J. Erektilné poruchy. 1. vydání, Osveta Martin 1994; 270 s.
    5. ©rámková T. Poruchy sexuality u somatických onemocnění a jejich léčba. Grada-Publishing, Praha 2013: 237.
    6. Santos T, Drummond M, Botelho F. Erectile dysfunction in obstructive sleep apnea syndrome - prevalence and determinants. Rev Port Pneumol 2012; 18(2): 64-71. Go to original source... Go to PubMed...
    7. De Busc R, Drory R, Goldstein I, et al. Management of sexual dysfunction in patients with cardiovascular disease: Recommendations of the Princeton Consensus panel. Am J Cardiol 2000; 86: 175-181. Go to original source... Go to PubMed...
    8. Rosen RC, Riley A, Wagner G, et al. The International Index of Eectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology, 1997; 49(6): 822-830. Go to original source... Go to PubMed...
    9. Goldstein I, Mulhall JP, Bushmakin AG, et al. The Erection Hardness Score and its relationship to successful sexual intercourse. J Sex Med 2008; 5: 2374-2380. Go to original source... Go to PubMed...
    10. SmPC sildenafil, tadalafil, vardenafil, avanafil avanafil 2013 www.sukl.cz/modules/medication/.
    11. Goldstein I, Lue TF, Padma-Nathan H, et al. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med 1998; 338: 1397-1404. Go to original source... Go to PubMed...
    12. Giuliano F, Mirone V, Xu L, et al. Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international randomised, parallel, placebo-controlled clinical trials. Euro Urol, 2012; 61: 917-925. Go to original source...
    13. Hatzichristou D, Gambla M, Rubio-Aurioles E. Efficacy of tadalafil once daily in men with diabetes mellitus and erectile dysfunction. Diabet Med, 2008; 25(2): 138-146. Go to original source... Go to PubMed...
    14. Goldstein I, McCullough A, Jones A, et al. A randomized-double-blind, placebo-controlled evaluation of the safety and efficacy of avanafil in subjects with erectile dysfunction. J Sex Med 2012; 9: 1122-1133. Go to original source... Go to PubMed...
    15. Goldstein I, Jones A, Belkoff LH, Karlin GS, Bowden CH, et al. Avanafil for the treatment of erectile dysfunction: a multicenter, randomied, double-blind study in men with diabetes mellitus. Mayo Clin Proc 2012; 87: 843-852. Go to original source... Go to PubMed...
    16. Mulhall JP, Moul JW, Wang R, Shin D, Engel JD, et al. A phase III, placebo-controlled study of the safety and efficacy of avanafil in the treatment of erectile dysfunction following bilateral nerve-sparing radical prostatectomy. J Sex Med 2012; 9: S42-43.
    17. Gruenvald I, Kitrey ND, Appel B. Low-intensity extracorporeal shock wave therapy in vascular disease and erectile dysfunction: theory and outcomes. Sex Med Rev, 2013; 1: 83-90. Go to original source... Go to PubMed...
    18. Heaton JP, Lording D, Liu SN, et al. Intracavernosal alprostadil is effective for the treatment of erectile dysfunction in diabetic men. Int J Impot Res, 2001; 13(6): 317-321. Go to original source... Go to PubMed...
    19. Scott FB, Bradley WE, Timm GW. Management of erectile impotence use of implantable inflatable prosthesis. Urology 1973; 2: 80-82. Go to original source... Go to PubMed...

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.